© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Letrozole stands out as a well-known chemical compound used in the field of medicine, primarily recognized as an aromatase inhibitor. This quality turns Letrozole into a key player for the treatment of hormone-responsive breast cancers, especially post-menopausal cases. Chemically, it bears the formula C17H11N5, indicating it contains carbon, hydrogen, and nitrogen atoms arranged in a way that enables its biological effects. Letrozole appears as a white to off-white crystalline powder, which immediately tells you something about its purity and preparation. A person with a background in chemistry may appreciate its distinct molecular structure, featuring a triazole ring fused with a benzonitrile group. This specific arrangement lends itself to both the compound’s physical properties and the mechanism by which it inhibits the aromatase enzyme.
Looking closer at the raw material, Letrozole has a molecular weight of 285.30 g/mol, and its density typically sits around 1.3 g/cm3. These numbers define more than just laboratory curiosity; they shape how the compound behaves in storage, blending, and when dissolved into a formulation. Letrozole’s melting point typically hovers between 184 and 185 degrees Celsius, so the product remains stable across a wide range of normal temperature conditions, minimizing concerns over unintentional degradation or transformation. It is not soluble in water, which means those handling the powder use either organic solvents for dissolving or suspension. The material comes in several forms—solid crystalline powder is the norm, but on rare occasions, it may also be processed into flakes or pearls for specialty manufacturing needs. A single gram of Letrozole powder takes up just under a milliliter in terms of volume, suggesting it packs densely and stores efficiently on chemical shelves. In liquid or solution form, it often remains stabilized in ethanol or dimethyl sulfoxide, ensuring consistent concentration and reactivity.
Taking a look at the Letrozole molecule, it features two nitrogen-rich rings connected by a cyano group, offering both stability and biological activity. For specialists working in synthesis or quality control, recognizing the signature aromatic and triazole rings underpins purity and batch consistency. Handling Letrozole comes with safety needs. As a chemical, Letrozole lands on material safety data sheets with warnings about potential harm—it is hazardous if swallowed, inhaled, or absorbed through skin. In acute medical exposure, it may lead to symptoms such as nausea, dizziness, or other disruptions to the body’s hormonal balance. To someone outside the scientific community, the raw material itself is not something for casual use; workplaces require gloves, goggles, and specialized ventilation. Further, disposal runs under local hazardous waste protocols, since letting pharmaceutical residues escape unmanaged impacts the environment and public health. Its specific HS Code, 2933299099, helps track and regulate international trade, placing Letrozole among other pharmaceutical raw materials for customs and compliance.
Letrozole is typically set aside for pharmaceutical formulation, used in the manufacture of tablets or solutions by companies specializing in endocrinology products. Its stability as a powder means it stores for months at a time without risk of breakdown. I’ve seen firsthand how forms such as powder, flakes, and pearls shape not just logistics, but also how easily labs can scale up production. In one local pharmaceutical lab, using a crystalline powder over a liquid concentrate allowed for faster analysis and reduced sample contamination. Density and solubility influence mixing times and the choice of excipient in drug formulation: denser solids like Letrozole tend to blend smoothly with carriers, ensuring consistent dosages down the production line. For research and commerce, the HS Code helps buyers and sellers know exactly what is being handled—no ambiguity, only standardization. Safety never takes a backseat since accidental inhalation exposes workers to real hormonal risks, highlighting why training and containment are non-negotiable.
Improving safety and handling starts with better labeling and storage. Labs and manufacturing plants benefit from clear documentation that lists molecular formula, density, and storage temperature up front. Regular staff training helps keep those who work with hazardous chemicals attentive and reduces incidents tied to complacency or inexperience. A robust chemical tracking system—leveraging the HS Code to avoid misidentification—spares logisticians costly delays and regulatory headaches. New research into environmentally responsible disposal could lessen the long-term impact of hazardous waste, pointing toward neutralization techniques and better waste stream management. In my experience, companies that put effort into comprehensive safety management report fewer injuries and stronger business continuity, paving the way for more responsible and efficient use of raw materials like Letrozole. Pharmaceutical regulators and manufacturers can collaborate to improve guidelines based on real-world usage data, making it easier to keep both people and the environment safe while supporting important advances in cancer treatment.
